Literature DB >> 25151

Acid esterase activity in cultured skin fibroblasts and amniotic fluid cells using 4-methylumbelliferyl palmitate.

G J Guy, J Butterworth.   

Abstract

The properties and levels of acid esterase in cultured skin fibroblasts and amniotic fluid cells were investigated using 4-methylumbelliferyl palmitate as substrate. Determinations of acid esterase activity could be made using as little as 1 microgram cell protein. Cardiolipin increased the activity 2--3 fold at the pH optimum 4.0. The apparent KM for both cell types studied was 196 micrometer without and 96 micrometer with cardiolipin. Acid esterase activity was inhibited by cyanide and thiomersal, but not by iodoacetate and N-ethylmaleimide. However activation by cardiolipin was prevented by iodoacetate, N-ethylmaleimide and also sodium chloride. Skin fibroblasts and primary amniotic fluid cells had similar levels with or without cardiolipin. A cyclic activity was found with subculture but no consistent pattern with passage. The acid esterase deficiency in Wolman's and cholesterol ester storage diseases was demonstrated with this substrate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25151     DOI: 10.1016/0009-8981(78)90253-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Separation and characterization of the acid lipase and neutral esterases from human liver.

Authors:  T G Warner; L M Dambach; J H Shin; J S O'Brien
Journal:  Am J Hum Genet       Date:  1980-11       Impact factor: 11.025

2.  Comparison of the substrate 4-methylumbelliferyl-alpha-l-iduronide with phenyl-alpha-L-iduronide for the diagnosis of Hurler's disease in cultured cells.

Authors:  J Butterworth; D M Broadhead
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

3.  Human beta-mannosidase deficiency: biochemical findings in plasma, fibroblasts, white cells and urine.

Authors:  A Cooper; C Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease.

Authors:  Jane E Potter; Gemma Petts; Arunabha Ghosh; Fiona J White; Jane L Kinsella; Stephen Hughes; Jane Roberts; Adam Hodgkinson; Kathryn Brammeier; Heather Church; Christine Merrigan; Joanne Hughes; Pamela Evans; Helen Campbell; Denise Bonney; William G Newman; Brian W Bigger; Alexander Broomfield; Simon A Jones; Robert F Wynn
Journal:  Orphanet J Rare Dis       Date:  2021-05-21       Impact factor: 4.123

5.  Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics.

Authors:  Francis Aguisanda; Charles D Yeh; Catherine Z Chen; Rong Li; Jeanette Beers; Jizhong Zou; Natasha Thorne; Wei Zheng
Journal:  Orphanet J Rare Dis       Date:  2017-06-28       Impact factor: 4.123

6.  A kinetic assay of total lipase activity for detecting lysosomal acid lipase deficiency (LAL-D) and the molecular characterization of 18 LAL-D patients from Russia.

Authors:  Nikolay Mayanskiy; Ekaterina Brzhozovskaya; Alexander Pushkov; Tatiana Strokova; Nikolay Vlasov; Andrej Surkov; Olga Gundobina; Kirill Savostianov
Journal:  JIMD Rep       Date:  2019-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.